Related Experiment Video
Updated: Aug 21, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells
Qunfang Li1, Sharlin Ahmed, Jeffrey A Loeb
1Department of Neurology and Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan 48201, USA.
Abstract:
Neuregulin (NRG) is a heparin-binding factor that activates members of the epidermal growth factor family of tyrosine kinase receptors including erbB2 that is overexpressed in more aggressive types of breast cancer. The exact role that NRG plays in breast cancer is complicated by the fact that NRG has been shown to have both proliferative and antiproliferative effects, depending on the breast cancer cell line used. Using an isogenic series of breast epithelial cell lines (MCF10A) ranging from benign to malignant, we found that the actions of NRG changed from antiproliferative to proliferative as the cells progress to cancer. This correlated with a progressive inability of NRG to down-regulate a group of proliferation genes identified previously using cDNA microarrays. As the cells progress to malignancy, they expressed higher levels of erbB2 and lower levels of erbB3 and secreted high levels of NRG into the culture media, resulting in high basal levels of erbB receptor phosphorylation. Disruption of this autocrine signaling loop by blocking ligand-induced receptor activation inhibited cancer cell proliferation. These results demonstrate that the transition of MCF10A cells from normal to premalignant to malignant correlates with the development of a constitutively active autocrine NRG signaling loop that promotes cell proliferation and suggest that disrupting this autocrine loop may provide an important therapeutic measure to control breast cancer cell growth.
Insights
Neuregulin (NRG) signaling shifts from inhibiting to promoting breast cancer cell proliferation as cells become malignant. Disrupting this NRG autocrine loop may offer a new breast cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Neuregulin (NRG) is a growth factor that activates epidermal growth factor receptors, including erbB2, which is often overexpressed in aggressive breast cancer.
- NRG's role in breast cancer is complex, exhibiting both proliferative and antiproliferative effects depending on the cell line.
- Understanding NRG's function is crucial for developing targeted breast cancer therapies.
Purpose of the Study:
- To investigate the changing role of Neuregulin (NRG) signaling in breast epithelial cells during malignant progression.
- To identify the molecular mechanisms underlying the switch from antiproliferative to proliferative effects of NRG.
- To explore the therapeutic potential of disrupting NRG signaling in breast cancer.
Main Methods:
- Utilized an isogenic series of MCF10A breast epithelial cell lines representing benign to malignant stages.
- Analyzed gene expression changes using cDNA microarrays.
- Assessed erbB receptor expression, NRG secretion, and receptor phosphorylation levels.
- Investigated the effect of blocking ligand-induced receptor activation on cancer cell proliferation.
Main Results:
- NRG's effect shifted from antiproliferative to proliferative as MCF10A cells progressed towards malignancy.
- Malignant cells showed increased erbB2, decreased erbB3, and high NRG secretion, leading to constitutive erbB receptor phosphorylation.
- NRG signaling formed an autocrine loop that promoted cancer cell proliferation.
- Inhibiting this autocrine loop by blocking receptor activation suppressed cancer cell growth.
Conclusions:
- The progression of breast epithelial cells to malignancy is associated with the development of a constitutively active, pro-proliferative NRG autocrine signaling loop.
- This autocrine loop is driven by altered erbB receptor expression and high NRG secretion.
- Disrupting this NRG autocrine signaling loop represents a potential therapeutic strategy for controlling breast cancer growth.
Related Concept Videos
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...

